References
1. CucinottaD, VanelliM: WHO declares COVID-19 a pandemic. Acta Biomed. Mattioli 1885, 2020, pp. 157–160.
2. ZhouP, YangXLou, WangXG, et al.: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature Nature Research, 2020;579:270–273.
3. WuZ, McGooganJM: Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J. Am. Med. Assoc. American Medical Association, 2020, pp. 1239–1242.
4. WangD, HuB, HuC, et al.: Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc American Medical Association, 2020;323:1061–1069.
5. HuangC, WangY, LiX, et al.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lancet Publishing Group, 2020;395:497–506.
6. GuoT, FanY, ChenM, WuX, ZhangL, HeT, WangH, WanJ, WangX, LuZ: Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol American Medical Association, 2020;.
7. Report sulle caratteristiche dei pazienti deceduti positivi a COVID-19 in Italia Il presente report è basato sui dati aggiornati al 20 Marzo 2020.
8. Characteristics and Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease in Northern Italy - PubMed [Internet]. [cited 2020 May 20],. Available from: https://pubmed.ncbi.nlm.nih.gov/32383763/?from_single_result=32383763&expanded_search_query=32383763
9. GreinJ, OhmagariN, ShinD, et al.: Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med Massachusetts Medical Society, 2020;.
10. FerrarioCM, JessupJ, ChappellMC, AverillDB, BrosnihanKB, TallantEA, DizDI, GallagherPE: Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005;111:2605–2610.
11. DonoghueM, HsiehF, BaronasE, GodboutK, GosselinM, StaglianoN, DonovanM, WoolfB, RobisonK, JeyaseelanR, BreitbartRE, ActonS: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87.
12. LetkoM, MarziA, MunsterV: Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol Nature Research, 2020;5:562–569.
13. WallsAC, ParkYJ, TortoriciMA, WallA, McGuireAT, VeeslerD: Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell Cell Press, 2020;181:281-292.e6.
14. ZhengYY, MaYT, ZhangJY, XieX: COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. Nature Research, 2020, pp. 259–260.
15. OuditGY, KassiriZ, JiangC, LiuPP, PoutanenSM, PenningerJM, ButanyJ: SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest 2009;39:618–625.
16. ZhouT, WangZ, FanJ, ChenS, TanZ, YangH, YinY: Angiotensin-converting enzyme-2 overexpression improves atrial remodeling and function in a canine model of atrial fibrillation. J Am Heart Assoc 2015;4:e001530.
17. Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglyc… - PubMed - NCBI [Internet]. [cited 2020 May 19],. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=24741027
18. LuYY, WuWS, LinYK, ChengCC, ChenYC, ChenSA, ChenYJ: Angiotensin 1-7 modulates electrophysiological characteristics and calcium homoeostasis in pulmonary veins cardiomyocytes via MAS/PI3K/eNOS signalling pathway. Eur J Clin Invest Blackwell Publishing Ltd, 2018;48.
19. ChenSA, ChangMS, ChiangBN, ChengKK, LinCI: Electromechanical effects of angiotensin in human atrial tissues. J Mol Cell Cardiol 1991;23:483–493.
20. MehtaP, McAuleyDF, BrownM, SanchezE, TattersallRS, MansonJJ: COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. Lancet Publishing Group, 2020, pp. 1033–1034.
21. QinC, ZhouL, HuZ, ZhangS, YangS, TaoY, XieC, MaK, ShangK, WangW, TianDS: Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis NLM (Medline), 2020;.
22. GuoY, LipGYH, ApostolakisS: Inflammation in atrial fibrillation. J. Am. Coll. Cardiol. Elsevier USA, 2012, pp. 2263–2270.
23. HuYF, ChenYJ, LinYJ, ChenSA: Inflammation and the pathogenesis of atrial fibrillation. Nat. Rev. Cardiol. Nature Publishing Group, 2015, pp. 230–243.
24. LeeSH, ChenYC, ChenYJ, ChangSL, TaiCT, WongcharoenW, YehHI, LinCI, ChenSA: Tumor necrosis factor-α alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci 2007;80:1806–1815.
25. Aschar-SobbiR, IzaddoustdarF, KorogyiAS, et al.: Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα. Nat Commun Nature Publishing Group, 2015;6.
26. DuncanDJ, YangZ, HopkinsPM, SteeleDS, HarrisonSM: TNF-α and IL-1β increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes. Cell Calcium Elsevier Ltd, 2010;47:378–386.
27. PrabhuSD: Cytokine-induced modulation of cardiac function. Circ. Res. 2004, pp. 1140–1153.
28. LazzeriniPE, Laghi-PasiniF, AcampaM, et al.: Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression. J Am Heart Assoc American Heart Association Inc., 2019;8.
29. BorthwickLA, WynnTA, FisherAJ: Cytokine mediated tissue fibrosis. Biochim. Biophys. Acta - Mol. Basis Dis. 2013, pp. 1049–1060.
30. ChungCC, LinYK, ChenYC, KaoYH, LeeTI, ChenYJ: Vascular endothelial growth factor enhances profibrotic activities through modulation of calcium homeostasis in human atrial fibroblasts. Lab Investig Springer Nature, 2020;100:285–296.
31. Castaño-RodriguezC, HonrubiaJM, Gutiérrez-ÁlvarezJ, et al.: Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis. MBio American Society for Microbiology, 2018;9.
32. SuetomiT, WillefordA, BrandCS, ChoY, RossRS, MiyamotoS, BrownJH: Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling. Circulation Lippincott Williams and Wilkins, 2018;138:2530–2544.
33. YaoC, VelevaT, ScottL, et al.: Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Circulation Lippincott Williams and Wilkins, 2018;138:2227–2242.
34. TangTT, LvLL, PanMM, WenY, WangB, LiZL, WuM, WangFM, CrowleySD, LiuBC: Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. Cell Death Dis Nature Publishing Group, 2018;9.
35. SappJL, AlqarawiW, MacIntyreCJ, TadrosR, SteinbergC, RobertsJD, LaksmanZ, HealeyJS, KrahnAD: Guidance On Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society. Can J Cardiol Elsevier BV, 2020;.
36. JanuaryCT, WannLS, CalkinsH, et al.: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation NLM (Medline), 2019;140:e125–e151.
37. CapelRA, HerringN, KallaM, YavariA, MiramsGR, DouglasG, BubG, ChannonK, PatersonDJ, TerrarDA, BurtonRAB: Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential. Hear Rhythm Elsevier B.V., 2015;12:2186–2194.
38. BotelhoAFM, PierezanF, Soto-BlancoB, MeloMM: A review of cardiac glycosides: Structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential. Toxicon. Elsevier Ltd, 2019, pp. 63–68.
39. WesslerJD, GripLT, MendellJ, GiuglianoRP: The P-glycoprotein transport system and cardiovascular drugs. J. Am. Coll. Cardiol. 2013, pp. 2495–2502.
40. Drug interactions with antimalarial medications in older travelers: a clinical guide. - PubMed - NCBI [Internet]. [cited 2020 May 19],. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=31776555
41. Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine. - PubMed - NCBI [Internet]. [cited 2020 May 19],. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=21233253
42. Rodríguez-MenchacaAA, Navarro-PolancoRA, Ferrer-VilladaT, RuppJ, SachseFB, Tristani-FirouziM, Sánchez-ChapulaJA: The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel. Proc Natl Acad Sci U S A National Academy of Sciences, 2008;105:1364–1368.
43. TaiCT, LinYK, LanFC, ChenHY, DingYA, ChangMS, ChenSA: Conduction Properties of the Crista Terminalis in Patients with Atrial Flutter Due to Amiodarone Therapy for Atrial Fibrillation. PACE - Pacing Clin Electrophysiol 2003;26:2241–2246.
44. TaiCT, ChiangCE, LeeSH, ChenYJ, YuWC, FengAN, DingYA, ChangMS, ChenSA: Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: Electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction. J Cardiovasc Electrophysiol Futura Publishing Company Inc., 1999;10:1180–1187.
45. TaiCT, ChenSA, FengAN, YuWC, ChenYJ, ChangMS: Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: Insights into the mechanism of termination. Circulation Lippincott Williams and Wilkins, 1998;97:1935–1945.
46. SpieziaL, BoscoloA, PolettoF, CerrutiL, TiberioI, CampelloE, NavalesiP, SimioniP: COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thromb Haemost [Internet] Thromb Haemost, 2020 [cited 2020 May 20];. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32316063
47. VioliF, PastoriD, CangemiR, PignatelliP, LoffredoL: Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost [Internet] Georg Thieme Verlag KG, 2020 [cited 2020 May 20];. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1710317
48. CuiS, ChenS, LiX, LiuS, WangF: Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost Wiley, 2020;.
49. KlokFA, KruipMJHA, van derMeerNJM, ArbousMS, GommersDAMPJ, KantKM, KapteinFHJ, vanPaassenJ, StalsMAM, HuismanMV., EndemanH: Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res Elsevier Ltd, 2020;.
50. AhmadI, RathoreFA: Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci [Internet] J Clin Neurosci, 2020 [cited 2020 May 20];. Available from: https://linkinghub.elsevier.com/retrieve/pii/S096758682031078X
51. COVID-19 and VTE-Anticoagulation - Hematology.org [Internet]. [cited 2020 May 20],. Available from: https://www.hematology.org/covid-19/covid-19-and-vte-anticoagulation
52. ChaoTF, ChiangCE, LinYJ, ChangSL, LoLW, HuYF, TuanTC, LiaoJN, ChungFP, ChenTJ, LipGYH, ChenSA: Evolving changes of the use of oral anticoagulants and outcomes in patients with newly diagnosed atrial fibrillation in Taiwan. Circulation. Lippincott Williams and Wilkins, 2018, pp. 1485–1487.
53. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibri… - PubMed - NCBI [Internet]. [cited 2020 May 19],. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=29562325
54. ReillyPA, LehrT, HaertterS, ConnollySJ, YusufS, EikelboomJW, EzekowitzMD, NehmizG, WangS, WallentinL: The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: The RE-LY trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). J Am Coll Cardiol 2014;63:321–328.
55. Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the E… - PubMed - NCBI [Internet]. [cited 2020 May 19],. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=30590425
56. CalkinsH, HindricksG, CappatoR, et al.: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Arrhythmia Elsevier B.V., 2017;33:369–409.
57. LakkireddyDR, ChungMK, GopinathannairR, et al.: Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Hear Rhythm Elsevier BV, 2020;.
58. Atrial Fibrillation in Heart Failure: What Should We Do? - PubMed [Internet]. [cited 2020 May 20],. Available from: https://pubmed.ncbi.nlm.nih.gov/26419625/?from_single_result=26419625&expanded_search_query=26419625
59. BelhadjerZ, MéotM, BajolleF, et al.: Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation [Internet] Circulation, 2020 [cited 2020 May 20];:CIRCULATIONAHA.120.048360. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.048360
60. PerkinsGD, MorleyPT, NolanJP, et al.: International Liaison Committee on Resuscitation: COVID-19 Consensus on Science, Treatment Recommendations and Task Force Insights. Resuscitation [Internet] Resuscitation, 2020 [cited 2020 May 20];151. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32371027
61. DrigginE, MadhavanMV., BikdeliB, et al.: Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J. Am. Coll. Cardiol. Elsevier USA, 2020, pp. 2352–2371.
62. GreenlandJR, MichelowMD, WangL, LondonMJ: COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. Anesthesiology NLM (Medline), 2020;.
63. Liverpool COVID-19 Interactions [Internet]. [cited 2020 May 20],. Available from: https://www.covid19-druginteractions.org/
Table 1. Interactions between medications for atrial fibrillation and COVID-19.